News

News and Press Releases
About the CF Foundation | Drug Pipeline | Antibiotics FDA Approves New Powder Form of CF Drug TOBI®

The U.S. Food and Drug Administration (FDA) has approved TOBI® Podhaler™ (tobramycin inhalation powder), a dry powder formulation of the antibiotic TOBI, to treat lung infections caused by the bacteria Pseudomonas aeruginosa (P. aeruginosa).

| 1 min read
About the CF Foundation | Infection Prevention and Control CF Foundation Updates Infection Prevention and Control Policy for All Foundation Events and Meetings

The Cystic Fibrosis Foundation recently updated its Infection Prevention and Control Policy for all Foundation events, meetings and offices to protect the health of people with cystic fibrosis.

| 2 min read
About the CF Foundation | Fundraising A Legacy of Sisterhood and Giving

It was the year of 1957 when Phyllis Kossoff, one of the earliest volunteers of the Cystic Fibrosis Foundation and mother of a child with CF, found herself standing before a room of women, asking for help.

| 4 min read
About the CF Foundation | Fundraising Activist Runs Across the U.S. to Raise Awareness, Support for CF Foundation Mission

Tommy Danger didn't know it then, but the day his best friend's son was born was the day Tommy's life changed forever.

| 3 min read